Sgrùdaidhean clionaigeach COPD ann an Oklahoma
Tha 8 sgrùdaidhean airson COPD a’ lorg phàirtichean aig làraichean ann an Oklahoma.
Bailtean ann an Oklahoma
Teacsa sgrùdaidh oifigeil (Beurla)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Norman
- Research Site, Oklahoma City
- Research Site, Tulsa
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Layrek Clinical Research- Site Number : 8400066, Tulsa
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Epic Medical Research - Chickasha- Site Number : 8400097, Chickasha
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Oklahoma City
- Research Site, Tulsa
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Oklahoma City
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Oklahoma City
- Research Site, Tulsa
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06878261eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Edmond
A’ fastadhÌre 3
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07177339Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hightower Clinical, Oklahoma City
A’ fastadhSgrùdadh amharc
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2025 · NCT06122077Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.